EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Reduced-Toxicity (BuFlu) Conditioning Is Better Tolerated but Has a Higher Second Transplantation Rate Compared to Myeloablative Conditioning (BuCy) in Children with Inherited Metabolic Disorders

Ashish Gupta, Michael Downey, Ryan Shanley, Cathryn Jennissen, Weston P Miller, Troy C Lund, Paul J Orchard, Angela R Smith

Biology of Blood and Marrow Transplantation · 2020-03 · 26 (3) · 486-492

DOI: 10.1016/j.bbmt.2019.11.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology of Blood and Marrow Transplantation, 2020-03. Verfasst von Ashish Gupta und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Blood and Marrow Transplant Program, University of Minnesota Masonic Children's Hospital, Minneapolis, Minnesota. Electronic address: gupta…. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Metabolic Diseases. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationMetabolic DiseasesBusulfanChildCyclophosphamideHumansMyeloablative AgonistsRetrospective StudiesTransplantation ConditioningVidarabine

Stichwörter der Autor:innen

Conditioning regimenGraft failureInherited metabolic disorders

Substanzen

Myeloablative AgonistsCyclophosphamideVidarabineBusulfan

Autor:innen und Institutionen

  • Pediatric Blood and Marrow Transplant Program, University of Minnesota Masonic Children's Hospital, Minneapolis, Minnesota. Electronic address: gupta461@umn.edu.
  • Pediatric Blood and Marrow Transplant Program, University of Minnesota Masonic Children's Hospital, Minneapolis, Minnesota.

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health

Zitieren

APA

Gupta, A., Downey, M., Shanley, R., Jennissen, C., Miller, W. P., Lund, T. C., Orchard, P. J., & Smith, A. R. (2020). Reduced-Toxicity (BuFlu) Conditioning Is Better Tolerated but Has a Higher Second Transplantation Rate Compared to Myeloablative Conditioning (BuCy) in Children with Inherited Metabolic Disorders. Biology of Blood and Marrow Transplantation, 26(3), 486-492. https://doi.org/10.1016/j.bbmt.2019.11.014

Vancouver

Gupta A, Downey M, Shanley R, Jennissen C, Miller WP, Lund TC, et al. Reduced-Toxicity (BuFlu) Conditioning Is Better Tolerated but Has a Higher Second Transplantation Rate Compared to Myeloablative Conditioning (BuCy) in Children with Inherited Metabolic Disorders. Biology of Blood and Marrow Transplantation. 2020;26(3):486-492. doi:10.1016/j.bbmt.2019.11.014

BibTeX
@article{Gupta2020,
  author = {Gupta, Ashish and Downey, Michael and Shanley, Ryan and Jennissen, Cathryn and Miller, Weston P and Lund, Troy C and Orchard, Paul J and Smith, Angela R},
  title = {Reduced-Toxicity (BuFlu) Conditioning Is Better Tolerated but Has a Higher Second Transplantation Rate Compared to Myeloablative Conditioning (BuCy) in Children with Inherited Metabolic Disorders},
  journal = {Biology of Blood and Marrow Transplantation},
  year = {2020},
  volume = {26},
  number = {3},
  pages = {486--492},
  doi = {10.1016/j.bbmt.2019.11.014}
}
Kostenlos starten →